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The unresponsive wakefulness syndrome (UWS), alsoknown as the vegetative state (VS), is one of the most
dramatic outcomes of acquired brain injury. Despite spon-
taneous eye opening and independent vital functions,
VS/UWS patients cannot functionally communicate their
thoughts or feelings and appear completely unaware of their
surroundings and themselves.1,2 VS/UWS has confronted
families, clinicians, society, and science with a variety of
clinical and ethical quests and dilemmas for >50 years.3,4
Uncertainty about the natural course of VS/UWS plays
a major part in many of these challenges. With a prevalence
of 0.2 to 6.1 patients per 100,000 inhabitants,5 it is classified
as a rare to ultrarare medical condition.6 Available figures on
recovery and survival arise mostly from well-organized clinical
environments in which VS/UWS patients receive specialized
postacute care.7–9 These, however, do not represent standard
practice.10,11 Fins coined the term “disordered care” to
describe the dire straits patients with disorders of conscious-
ness and their families in the USA were in in 2013.10 The
evidence with regard to the expected outcome in patients in
VS/UWS was characterized as “limited” in a 2018 review by
the American Academy of Neurology (AAN).12,13
Data about survival and end-of-life scenarios in
VS/UWS are of particular importance to the ongoing
international debate on decision-making in prolonged dis-
orders of consciousness (PDOC). The view on discontinu-
ation of artificial nutrition and hydration (ANH) in these
patients varies greatly between countries.4,11,14–17
Although in the United States, discontinuation of ANH
has been lawful since the Cruzan ruling in 1990,18
the responsibility for clinical decision-making lies with
the incapacitated patient’s surrogates and may involve the
court (eg, the case of Terri Schiavo19). The United Kingdom
recently moved the responsibility for end-of-life decisions in
PDOC from the courtroom back to the clinic.20,21 In
France, the summer of 2019 brought a tug of war about the
discontinuation of ANH in a patient who had been in
VS/UWS for 11 years.22 Those involved in, or confronted
by, such paradigm shifts and public discussions, are in need
of clear scientific descriptions of how VS/UWS patients fare
in real-life settings.
Since the 1990s, a medical–ethical–legal framework
in the Netherlands has allowed for withdrawal of ANH in
VS/UWS once chances of recovery of consciousness have
become negligible.4,23,24 Contrary to the USA, in the
Netherlands the responsibility for such decisions lies with
the treating physician. Up until 2019, specialized PDOC
rehabilitation was only reimbursed for patients younger
than 25 years. Next to this threshold for postacute rehabil-
itation, over the years a highly professional long-term care
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practice developed. A specific academic medical specialty
for working in nursing homes and in primary care was
established. This medical discipline, called "elderly care
medicine" (formerly known as nursing home medicine), is
dedicated to patient-centered care for the elderly, but also
for young patients with the severest sequelae of neurologi-
cal diseases.25,26 Dutch elderly care medicine has a tradi-
tion of research whose topics include VS/UWS.
Specifically, decision-making and end-of-life scenarios in
VS/UWS have been studied retrospectively and in case
reports since the 1990s.27–31
The Netherlands have the lowest VS/UWS preva-
lence documented worldwide.5,32 Nonetheless, prolonged
and extremely prolonged VS/UWS, even beyond 25 years
after the causative injury, occurs as well, often associated
with conflicts between relatives and medical staff about
life-prolonging medical treatment.29–32
A nationwide dynamic cohort study, carried out
between 2012 and 2018, allows us to present the outcomes
of VS/UWS patients in this particular context. Extensive
descriptions of the study methods and results are available
as Supplementary Material at https://ukonnetwerk.nl/
outcomes_from_a_vicious_circle_supplements.
The study involved hospitals, rehabilitation centers,
nursing homes, and patients cared for at home. Level of
consciousness was quantified with the Coma Recovery
Scale–Revised (CRS-R),33 at inclusion and during up to
6 years of follow-up, by the same formally trained and
experienced clinician (W.S.v.E.). Patients’ families were
invited to actively participate in the assessment. Treating
physicians provided their patients’ clinical characteristics.
Patients’ trajectories through the health care system and
aspects of the care they received were investigated/recorded/
registered as well. When an included patient died, the
treating physician was asked to fill in a questionnaire on
the cause of death, its circumstances, and events and deci-
sions preceding it. All posthumous data were verified with
the treating physician by telephone, to prevent misinterpre-
tation regarding treatment scenarios and causes of death,
which are difficult to capture in questionnaires.34 Physicians
were also invited to share any challenges, positive experi-
ences, or peculiarities they had encountered while caring for
the included patient.
As VS/UWS is extremely rare in the Netherlands,32
we allowed for variable time post ictus at inclusion and
scheduled follow-up accordingly. This meant that a patient
included at 1 month post ictus would receive 4 measure-
ments within the first year, whereas someone in VS/UWS
included at 3 years post ictus would be assessed once
per year.
Over the course of 6 years, 59 patients possibly eligi-
ble for inclusion were clinically evaluated by the
researcher; 28 of them (47%) were found to be in a mini-
mally conscious state (MCS). This resulted in a study
population of 31 patients with a diagnosis of VS/UWS.
Nineteen patients (61%) were included within 1 year after
the incident, and the average time post ictus at inclusion
was 3.5 years (standard deviation [SD] = 7 years,
range = 1 month–33 years). Seventy-one percent of
included patients had sustained nontraumatic brain injury,
most often during an out-of-hospital cardiac arrest (10/31
patients, 32% of the total group).
Of the 28 patients who had already been discharged
from hospital at baseline, only 1 (4%) had followed spe-
cialized rehabilitation in a clinical rehabilitation center
within the Netherlands. Six patients (21%) had received a
correct level of consciousness diagnosis (either VS or
UWS) at hospital discharge. The others’ conditions were
described as “poor neurological recovery,” a Glasgow
Coma Scale score, or by stating the etiology (eg, “sub-
arachnoid hemorrhage”). At nursing home admission, a
diagnosis of VS/UWS was made in 11 cases (39%). There
was no mention of CRS-R scores accompanying any of
the hospital or nursing home diagnoses.
The treating physician was an elderly care physician
in 18 of 31 cases (58%), a resident or junior doctor in
10 cases (32%), a neurologist in 3 cases, and a general prac-
titioner in 1 case.
During the total course of the study, 6 patients
emerged from VS/UWS (see Supplementary Material for
the extensive methodology and results). Three patients
were alive in VS/UWS when the study ended. Four
patients, all confirmed to be alive when the study ended,
were lost to follow-up because of nonrespondent physi-
cians. Eighteen of 31 patients died during the course of
the study. Eleven of them did so within 2 years post
ictus; the others died between 4 and 33 years post ictus.
Mean age at death was 50 years (SD = 12 years,
range = 26–67 years). We will now zoom in on the data
we obtained in relation to the end of life in VS/UWS
patients.
Scenarios of dying are listed in the Table. Three
patients were unexpectedly found deceased, 1 presumably
due to an epileptic seizure causing hypoxemia, whereas
the causes of death in the other 2 remained unclear, even
after autopsy in 1 case. Another patient died due to sud-
den respiratory failure despite curative treatment. Two
died after a decision not to treat a new, life-threatening
complication (eg, pneumonia). Nine of 18 deaths (50%)
occurred after withdrawal of ANH.
All physicians in charge of these 9 cases were elderly
care physicians, 4 of whom had expressed the intention to
withdraw ANH in this case earlier in the study. Based on
the questionnaires (n = 9) and telephone verification
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(n = 7), every decision to withdraw ANH was tied to a spe-
cific event or development. This “trigger” was a somatic
complication such as an infection in 5 cases. A factor
unrelated to the patient’s clinical condition led to the deci-
sion in the other 4. Two arose from the research itself (eg,
repeated confirmation of the diagnosis by an expert not
affiliated with the patient’s care facility). In the other 2, a
dysfunctional feeding tube led to ANH being withdrawn.
All physicians considered themselves responsible for this
decision; 3 of them felt they shared responsibility with the
patient’s relatives. According to the physicians, none of the
decisions was made without the relatives’ consent.
Detailed information on the patient’s last days was
obtained in 7 cases. After discontinuation of ANH, all
patients were, either proactively or reactively, treated with
midazolam and morphine to alleviate signs of possible dis-
comfort. Antiepileptic drugs were abruptly stopped in the
3 patients who had been receiving them; 2 of them devel-
oped seizures. The time span between withdrawal of
ANH and death varied. Two patients, both with severe
TABLE: End-of-Life Scenarios in Deceased Vegetative State/Unresponsive Wakefulness Syndrome Patients
(n = 18)
Sex; Age, yr Etiology Time Post Ictus
Cessation of ANH
M; 45 TBI 4 mo
M; 57 OHCA 5 mo
M; 45 OHCA 5 mo
F; 44 TBI 9 mo
M; 26 Non-TBI miscellaneous 1 yr
F; 55 Non-TBI miscellaneous 7 yr, 4 mo
F; 50 SAH 7 yr, 4 mo
F; 38 TBI 20 yr
F; 59 OHCA 33 yr, 5 mo
New life-threatening complication, no
treatment
F; 65 Non-TBI miscellaneous 1 yr, 1 mo
M; 66 OHCA 1 yr, 2 mo
New life-threatening complication, died
despite treatment
F; 66 OHCA 5 yr, 3 mo
Unexpected death of unknown cause
F; 29 Non-TBI miscellaneous 5 mo
F; 52 Non-TBI miscellaneous 1 yr, 9 mo
F; 54 SAH 9 yr, 6 mo
Missing
F; 35 OHCA 4 mo
M; 50 TBI 8 mo
M; 55 OHCA 4 yr, 5 mo
ANH, artificial nutrition and hydration; F, female; M, male; OHCA, out-of-hospital cardiac arrest; SAH, subarachnoid hemorrhage; TBI, traumatic
brain injury.
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complications and comorbidity (ileus, diabetes mellitus
type 1), died within 48 hours. Four others survived for
>1 week, 1 somatically healthy man in his 40s even for
18 days. In 3 of these cases lasting for >1 week, treating
physicians mentioned unprompted that they had felt the
“emaciation” (physicians’ quotes) that occurred after
ANH was discontinued to have compromised the
“patient’s dignity” (physicians’ quotes). Two physicians
spontaneously reported being asked by family members
“to euthanize the patient” (physicians’ quotes). In accor-
dance with the strict euthanasia regulations in place in the
Netherlands, these requests were not granted.35
How do these observations relate to what was
already known about dying in PDOC? Somatic complica-
tions are associated with mortality in VS/UWS, either
despite treatment or after a decision to withhold treat-
ment.29,30,36 In a retrospective Dutch study on
43 VS/UWS deaths between 2000 and 2003, death after
withholding treatment for a new complication was the pri-
mary scenario in 56% of cases.30 A decade later, the pri-
mary scenario at the end of life in VS/UWS patients in
the Netherlands has become death after withdrawal of
ANH, in 50% of cases. This is a substantial increase com-
pared to 2000–2003, when this happened in only 21% of
deaths.30
Dutch law states that any medical treatment has to
be in accordance with medical professional standards and
requires the patient’s consent or that of their surrogate.37
It is the treating physician’s responsibility to ensure that
the treatment he or she provides meets both criteria. In
unresponsive patients receiving medical treatment in the
form of ANH, this reverse burden of proof is complex in
2 ways.
First, the medical professional standard regarding
ANH in VS/UWS is not entirely clear. As we mentioned
above, in the late 1990s authoritative Dutch reports stated
that ANH should not be continued if it at best results in
prolonging life in VS/UWS with no chance of recov-
ery.4,23,24 The exact moment this chance has passed, how-
ever, cannot be determined with certainty. Although the
recent AAN guideline states that a patient’s prognosis
should not be considered poor within the first 28 days
postinjury, it does not explicitly mention when recovery
does become unlikely.12 It is now generally accepted that
patients may recover consciousness well into the second
year after their injuries,12,38 but their functional outcome,
let alone quality of life, is unknown. Moreover, there is no
gold standard for the diagnosis of VS/UWS. Clinical mis-
diagnosis occurs in about 40% of cases.32,39,40 To compli-
cate matters further, even among adequately assessed
VS/UWS patients, in a significant proportion brain activ-
ity patterns compatible with higher cognitive function can
be detected with advanced diagnostic techniques.41–43
Such techniques are not yet part of routine clinical care.
In other words, in trying to predict the yield of ANH in
VS/UWS in a purely medical sense, a physician faces seri-
ous diagnostic and prognostic uncertainty.
Second, the process of determining whether an indi-
vidual patient in clinical VS/UWS would have given con-
sent to receive ANH is challenging. The patients cannot
speak for themselves. The family is invariably struck by a
combination of hope, grief, and uncertainty, and some-
times feelings of guilt and anger, that parallels the emo-
tions relatives experience in missing person cases.44
This further aggravates the already complex task of speak-
ing on behalf of a loved one. Shared decision-making
takes time and skill, especially in prolonged disorders of
consciousness,10,13,28,29,45,46 and requires adequate psy-
chosocial guidance of the patient’s family. In addition, the
family must weigh the same uncertain diagnostic prognos-
tic information the physician has at their disposal.
In our study, the decision to discontinue ANH was
made by the physician, never by a junior doctor or resi-
dent and, according to the physicians involved, never
against the relatives’ wishes. Although the physicians in
our cohort considered it their responsibility to discontinue
ANH, in all 9 cases the timing of ANH withdrawal was
linked to a specific and sometimes seemingly haphazard
event such as a new complication or a dysfunctional per-
cutaneous endoscopic gastrostomy system. The timeframe
in which life-prolonging treatment in VS/UWS may be
stopped, also called “the window of opportunity,” is classi-
cally situated in the first year after onset.47,48 In our study,
however, we observed such decisions being made in
patients in extremely prolonged VS/UWS as well, even
after >33 years. It seems that these heavy deliberations
require the momentum of an external trigger, and that
that trigger may even appear after decades of status quo.
Dying after discontinuation of ANH has been
described as peaceful and calm in previous publica-
tions.27,29,36,49,50 and this is an observation shared by
various physicians in our study. Some patients, however,
developed seizures after the sudden discontinuation of
antiepileptic drugs, and others’ bodies changed un-
recognizably due to emaciation. Especially when a pro-
longed period of time, up to 18 days, went by between
the moment of ANH withdrawal and the patient passing
away, physicians described a “burden of witness,”50 as
experienced by both themselves and the patients’ families.
In 3 cases, they even considered this process to have com-
promised the patient’s dignity. Symptomatic treatment,
including palliative sedation, is unlikely to relieve this bur-
den.51 In the absence of a patient’s own willful and consis-
tent request for active life termination, and of definite
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unbearable suffering without prospect of improvement,
euthanasia is illegal in the Netherlands.35 The question
remains whether a family’s suffering could ever be reason
to discard these requirements, or that that would that lead
to a slippery slope.
Our cohort of 31 VS/UWS patients in the Nether-
lands paints a bleak picture of the situation of some of the
most vulnerable patients in modern neurological practice.
Seventy-nine percent received an incorrect and/or out-
dated diagnosis at hospital discharge. Only 1 patient was
allowed specialized clinical rehabilitation. Patients emerg-
ing to (minimal) consciousness were far outnumbered by
those who died, and 50% of VS/UWS deaths were pre-
ceded by a physician’s decision to discontinue ANH.
Our study also testifies of the challenges of investigat-
ing an ultrarare condition with a high mortality in the
absence of adequate routine diagnostics, in a context of
fragmented care without a central registry. Recruitment
proved difficult, and some patients were lost even after
years of follow-up. It is likely that we missed patients recov-
ering relatively soon after their injuries. Kaplan–Meier cur-
ves and recovery rates could not be calculated due to
variable times postictus at inclusion and inclusion bias.
Moreover, single assessment–based determination of level
of consciousness has been associated with diagnostic
error,52 especially if no accessory diagnostics are deployed.
The possibility of having underestimated the included
patients’ level of consciousness becomes greater when we
consider that in only 9% of CRS-R assessments were no
factors possibly influencing the measurements identified.
However, research publications on VS/UWS populations
have rarely taken such factors into account, nor have
repeated assessments (eg, 5 measurements within 14 days52)
been deployed in nationwide, prospective studies.
“Why bother,” one might ask, “investing in future
epidemiological research on PDOC anyway?”
To answer this harsh but fair question, we should
first acknowledge that modern medicine has a special obli-
gation to patients who survive the worst kinds of acquired
brain injury with PDOC. After all, if it were not for the
medical–technological advances of the past 50 years, none
of these individuals would have survived in the state they
are in. Unfortunately, in many cases this survival leads to
a vicious circle. In VS/UWS, epidemiology, organization
of care, and end-of-life decisions are strongly inter-
connected (Fig.). Step 1: The group of patients seems
small and recovery is rarely witnessed, especially by those
responsible for care in the acute phase. Step 2: Because of
the supposed small numbers and modest chances of mean-
ingful recovery, care is organized ad hoc, resulting in mis-
diagnosis, shattered expertise, and lack of specialized
rehabilitation and family counseling. Step 3: Decisions
about whether to continue life-supporting treatment are
made without solid diagnosis or scientifically sound prog-
nostics, often by a physician without knowledge of the
possible long-term outcomes and without a concrete
roadmap to adequate postacute and long-term care. This
brings us back to step 1; the number of patients and their
chances of recovery remain small due to a tendency to dis-
continue life-prolonging treatment, and those who survive
continue to receive suboptimal care.
In order to break this vicious circle, recommenda-
tions flowing from our study results address clinicians, sci-
entists, and policy makers and revolve around 3 themes.
First of all, patients with prolonged disorders of conscious-
ness deserve accurate and timely diagnoses. The distinc-
tion between VS/UWS and MCS is of major clinical
importance; minimal signs of consciousness are associated
with intact nociception and better chances of
recovery,12,53 and also translate to different ethical consid-
erations. A mobile, outreaching team of experts could pro-
vide routine on-site CRS-R assessments and refer patients
to specialized diagnostic facilities while simultaneously
instructing local staff and relatives on behavioral signs of
consciousness. It would seem useful to anonymously store
these data in a central registry, so that up-to-date preva-
lence, incidence, and other epidemiologic outcomes would
become available. Second, physicians must be facilitated
to reach specific competencies needed in PDOC care, for
example, diagnostics, therapeutic regimes, interdisciplinary
collaboration, informing and guiding the patient’s family,
and end-of-life decisions, when (or preferably before) they
FIGURE: Interconnection of epidemiology, organization of
care, and end-of-life decisions in vegetative state/
unresponsive wakefulness syndrome.
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are put in charge of such patients. Third, the way in
which treatment decisions are made by physicians, how
they are experienced by the families involved, and what
their results are in terms of quality of life and quality of
dying, have been described in monographs (eg, Fins46)
but must be studied further using qualitative and quanti-
tative methods combined. Such studies could identify the
critical factors contributing to relatively early, late, and
absent treatment decisions, and help construct the optimal
trajectory for decision-making in PDOC along the chain
of care that supports patients, families, and health care
professionals alike, as recommended in recent guidelines
and reports from the AAN, the Royal College of Physi-
cians, and the Brain Foundation Netherlands.12,20,54
That critical decisions about the medical treatment
of some of the most helpless patients in modern medicine
can be made by dedicated physicians, in close deliberation
with those patients’ relatives and without judicial, legal, or
media interference, can be considered a merit. However,
the very responsibility that comes with this merit compels
us to also provide optimal facilitation of recovery during
the period of time when that recovery might take place.
Patients’ potential must be supported with the same per-
sonalized care and compassion as the decision to discon-
tinue treatment when that hoped-for recovery does not
occur. With adequate collaboration between scientists, cli-
nicians, and policymakers, neither patients with prolonged
disorders of consciousness, nor their families, should have
to fall between the cracks of a disordered care system.
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